|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/08 | (2006.01) |
| B01D 61/22 | (2006.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 38/36 | (2006.01) | ||
| A61P 7/04 | (2006.01) |
| (11) | Number of the document | 2244814 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08866246.5 |
| Date of filing the European patent application | 2008-12-23 | |
| (97) | Date of publication of the European application | 2010-11-03 |
| (45) | Date of publication and mention of the grant of the patent | 2021-06-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/088201 |
| Date | 2008-12-23 |
| (87) | Number | WO 2009/086400 |
| Date | 2009-07-09 |
| (30) | Number | Date | Country code |
| 1741807 P | 2007-12-28 | US | |
| 1788107 P | 2007-12-31 | US |
| (72) |
MATTHIESSEN, Peter , AT
TURECEK, Peter , AT
SCHWARZ, Hans-Peter , AT
SCHNECKER, Kurt , AT
|
| (73) |
Takeda Pharmaceutical Company Limited ,
1-1, Doshomachi 4-chome,
Chuo-ku,, Osaka-shi, Osaka,
JP
|
| (54) | RECOMBINANT VWF FORMULATIONS |
| RECOMBINANT VWF FORMULATIONS |